These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 16267037)
1. Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. Kenny LM; Vigushin DM; Al-Nahhas A; Osman S; Luthra SK; Shousha S; Coombes RC; Aboagye EO Cancer Res; 2005 Nov; 65(21):10104-12. PubMed ID: 16267037 [TBL] [Abstract][Full Text] [Related]
2. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944 [TBL] [Abstract][Full Text] [Related]
3. Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography. Kenny L; Coombes RC; Vigushin DM; Al-Nahhas A; Shousha S; Aboagye EO Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1339-47. PubMed ID: 17333178 [TBL] [Abstract][Full Text] [Related]
5. Early detection of tumor response to chemotherapy by 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo. Leyton J; Latigo JR; Perumal M; Dhaliwal H; He Q; Aboagye EO Cancer Res; 2005 May; 65(10):4202-10. PubMed ID: 15899811 [TBL] [Abstract][Full Text] [Related]
6. [¹⁸F]fluorothymidine-positron emission tomography in patients with locally advanced breast cancer under bevacizumab treatment: usefulness of different quantitative methods of tumor proliferation. Marti-Climent JM; Dominguez-Prado I; Garcia-Velloso MJ; Boni V; Peñuelas I; Toledo I; Richter JA Rev Esp Med Nucl Imagen Mol; 2014; 33(5):280-5. PubMed ID: 25066253 [TBL] [Abstract][Full Text] [Related]
7. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975 [TBL] [Abstract][Full Text] [Related]
8. Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis. Chalkidou A; Landau DB; Odell EW; Cornelius VR; O'Doherty MJ; Marsden PK Eur J Cancer; 2012 Dec; 48(18):3499-513. PubMed ID: 22658807 [TBL] [Abstract][Full Text] [Related]
10. Altered tissue 3'-deoxy-3'-[18F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography. Kenny LM; Contractor KB; Stebbing J; Al-Nahhas A; Palmieri C; Shousha S; Coombes RC; Aboagye EO Clin Cancer Res; 2009 Nov; 15(21):6649-57. PubMed ID: 19861447 [TBL] [Abstract][Full Text] [Related]
11. How Long of a Dynamic 3'-Deoxy-3'-[ Zhang J; Liu X; Knopp MI; Ramaswamy B; Knopp MV Mol Imaging Biol; 2019 Apr; 21(2):382-390. PubMed ID: 29987617 [TBL] [Abstract][Full Text] [Related]
12. In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Vesselle H; Grierson J; Muzi M; Pugsley JM; Schmidt RA; Rabinowitz P; Peterson LM; Vallières E; Wood DE Clin Cancer Res; 2002 Nov; 8(11):3315-23. PubMed ID: 12429617 [TBL] [Abstract][Full Text] [Related]
13. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography. Yap CS; Czernin J; Fishbein MC; Cameron RB; Schiepers C; Phelps ME; Weber WA Chest; 2006 Feb; 129(2):393-401. PubMed ID: 16478857 [TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas. Muzi M; Spence AM; O'Sullivan F; Mankoff DA; Wells JM; Grierson JR; Link JM; Krohn KA J Nucl Med; 2006 Oct; 47(10):1612-21. PubMed ID: 17015896 [TBL] [Abstract][Full Text] [Related]
16. Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapy. Contractor K; Challapalli A; Tomasi G; Rosso L; Wasan H; Stebbing J; Kenny L; Mangar S; Riddle P; Palmieri C; Al-Nahhas A; Sharma R; Turkheimer F; Coombes RC; Aboagye E Phys Med Biol; 2012 Jun; 57(11):3419-33. PubMed ID: 22572708 [TBL] [Abstract][Full Text] [Related]
17. Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography. Contractor KB; Kenny LM; Stebbing J; Challapalli A; Al-Nahhas A; Palmieri C; Shousha S; Lewis JS; Hogben K; De Nguyen Q; Coombes RC; Aboagye EO Nucl Med Commun; 2011 Nov; 32(11):997-1004. PubMed ID: 21862943 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of 3'-deoxy-3'-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas. Shinomiya A; Kawai N; Okada M; Miyake K; Nakamura T; Kushida Y; Haba R; Kudomi N; Yamamoto Y; Tokuda M; Tamiya T Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):175-85. PubMed ID: 23229746 [TBL] [Abstract][Full Text] [Related]
19. Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer. Yamamoto Y; Nishiyama Y; Ishikawa S; Nakano J; Chang SS; Bandoh S; Kanaji N; Haba R; Kushida Y; Ohkawa M Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1610-6. PubMed ID: 17530250 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. Pio BS; Park CK; Pietras R; Hsueh WA; Satyamurthy N; Pegram MD; Czernin J; Phelps ME; Silverman DH Mol Imaging Biol; 2006; 8(1):36-42. PubMed ID: 16362149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]